FDA Inspection
STATE HEALTH SERVICES, TEXAS DEPARTMENT OFSTATE HEALTH SERVICES, TEXAS DEPARTMENT OF – FDA Inspection, May 20, 2026
Record Details
This FDA Inspection record concerns STATE HEALTH SERVICES, TEXAS DEPARTMENT OF, with an inspection on May 20, 2026, issued by the Dallas District Office, covering human drugs.
- Office
- Dallas District Office
- Person
View Company Profile
ID · 6e26fcc8-96d6-423d-8e5e-1ec941ba8197
Inspection Facts
- Inspection number
- 1318344
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of STATE HEALTH SERVICES, TEXAS DEPARTMENT OF
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 14, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for STATE HEALTH SERVICES, TEXAS DEPARTMENT OF
- FDA Inspection 1094899 - 2019-05-16
- FDA Inspection 657063 - 2010-04-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.